HealthcareOn the MoveCymaBay Therapeutics stock gains after CEO buys shares worth $100KJun. 07, 2022 10:20 AM ETCymaBay Therapeutics, Inc. (CBAY) StockBy: Niloofer Shaikh, SA News Editor CymaBay Therapeutics (NASDAQ:CBAY) stock edge higher after disclosing that its CEO Sujal Shah bought 51.301K shares of common stock on 6 June. As per regulatory filing, shares were purchased at $1.95, for total transaction size of $100K. Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgCBAY--CymaBay Therapeutics, Inc.Trending AnalysisTrending News